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Abstract
Background: IL-1beta has been implicated in inflammatory episode. In view of the inflammatory
nature of cancer cachexia, we determined the predictive value of IL-1B-31 T/C, -511 C/T, +3954
C/T and IL-1RN VNTR gene polymorphisms on the occurrence of cachexia associated with locally
advanced gastric cancer.
Methods: The study included 214 patients and 230 healthy volunteers. Genomic DNA was
prepared from peripheral blood leukocytes. Genotypes and allele frequencies were determined in
patients and healthy controls using restriction fragment length polymorphism analysis of
polymerase chain reaction products.
Results: The overall frequencies of IL-1B-31 T, -511 T, +3954 T and IL-1RN VNTR alleles in
patients with locally advanced gastric cancer were all comparable with those in controls. No
significant differences were found in the distribution of IL-1B-31 T, -511 T and IL-1RN VNTR
between patients with cachexia and without. Patients with cachexia showed a significantly higher
prevalence of IL-1B+3954 T allele than those without (P = 0.018). In a logistic regression analysis
adjusted for actual weight, carcinoma location and stage, the IL-1B+3954 CT genotype was
associated with an odds ratio of 2.512 (95% CI, 1.180 – 5.347) for cachexia.
Conclusion: The IL-1B+3954 T allele is a major risk for cachexia from locally gastric cancer.
Genetic factors studied are not likely to play an important role in the determination of susceptibility
to locally advanced gastric cancer.
Background
Cancer cachexia is a syndrome characterized by a marked
weight loss, anorexia, asthenia and anaemia, accounting
for at least 20% of deaths in neoplastic patients [1].
Unlike starvation, which depletes fat stores form adipose
tissue while conserving protein from the wasting of skele-
tal muscle, in cachexia neither fat nor protein is spared.
Progressive weight loss is a common feature of cancer and
is responsible not only for a poor quality of life and poor
response to chemotherapy, but also short survival time
irrespective of tumor mass or the presence of metastases,
and it also interferes with cancer therapy [2]. Although the
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mechanism of cancer cachexia remains largely unre-
solved, several key mediators have been identified. One
set is proinflammatory cytokines [3], including TNF-α, IL-
1β, IL-6 and IFN-γ [4,5]. In humans, there is increasing
evidence that the host's cytokine response is genetically
determined. Polymorphic gene sequences of certain
cytokines could be potential markers of susceptibility and
clinical outcome in different human infectious diseases.
However, to the best of our knowledge, no study has
addressed the correlation of cytokine polymorphisms of
IL-1β gene with the likelihood of cachexia from locally
advanced gastric cancer.
IL-1β is a potent proinflammatory cytokine released by
macrophages in systemic inflammatory responses. It not
only has important biologic effect but also regulates
inflammatory reaction and immune response through
promoting other cytokines expressions, such as IL-6 and
IL-12. Studies have documented constitutive IL-1β pro-
tein production in human and animal cancer cell lines
including sarcomas and ovarian and transitional cell car-
cinomas. Solid tumors in which IL-1β has been shown to
be up regulated include breast, colon, lung, head and neck
cancers, and melanomas, and patients with IL-1β produc-
ing tumors have generally bad prognoses. It has also been
reported that this cytokine was the factor responsible for
enhanced protein degradation in rats, and repeated
administration of IL-1 to rats induced anorexia and
weight loss [6]. In vivo, the potentially injurious proin-
flammatory effects of IL-1β are counterbalanced by the
action of the interleukin-1 receptor antagonist (IL-1RN)
[7]. Extensive evidence indicates that the biologic func-
tion of secreted IL-1RN is to competitively inhibit the
binding of circulating IL-1β to cell-surface receptors [8,9],
and IL-1RN levels increase late during the course of an
inflammatory event to terminate acute inflammation [7].
The production of IL-1β and IL-1RN are depended on sev-
eral factors, there is increasing evidence that the genetic
factors plays an important role. The IL-1B and the IL-1RN
genes are located on chromosome 2q14, within a 360 kb
region. In the IL1B gene there are two diallelic polymor-
phisms at positions -511, -31 in the promoter region and
at position + 3954 in the fifth exon. The IL-1RN gene has
a penta-allelic polymorphic site in intron 2 containing
variable numbers of an 86 bp tandem repeat sequence. In
recent years, in vitro and in vivo studies have indicated
that IL-1B -511 T and +3954 T alleles enhance IL-1β and
IL-1RN productions and the circulating levels of the two
cytokines in humans [10,11]. It has been reported that
proinflammatory genotypes of the interleukin-1 loci were
associated with a significantly increased risk of a chronic
hypochlorhydric response to H. pylori infection and gas-
tric cancer in a Caucasian population, presumably by
altering IL-1β levels in the stomach [12,13], but an influ-
ence of IL-1β gene polymorphisms on susceptibility of
cachexia from gastric cancer has not been evaluated. In
view of the roles of IL-1β played in cachexia, we postu-
lated that its polymorphisms might have some associa-
tion with the development of cancer cachexia.
The causes of cachexia are thought to be multifactorial but
primarily related to hypercatabolism and loss of appetite
due to circulating tumor-related substances and cytokines
[14,15]. Working from assumption of substantial inflam-
matory contribution to cancer cachexia, we hypothesized
that IL-1B-31 T/C, -511 C/T, +3954 C/T and IL-1RN gene
polymorphisms have some relationship with the develop-
ment of cachexia associated with locally advanced gastric
cancer. We also determined whether the gene polymor-
phisms studied were associated with the susceptibility to
locally advanced gastric cancer.
Methods
Study population
The protocol was approved by the local Ethics Committee,
and informed consent was obtained from each of the
patient or a close relative. All of the consecutive patients
with locally advanced gastric cancer from June 1, 2004 to
June 1, 2006 were prospectively considered. To be eligible
for enrollment, all of the subjects had to be Chinese Han
Population. The exclusion criteria were the following: (1)
anorexia nervosa; (2) pyloric obstruction; (3) major gas-
trointestinal disease, chronic renal failure, diabetes and
HIV; (4) hepatic, peritoneal, pelvic and distant metastasis;
(5) consanguineous mating. Immediately after admission
and before any surgical or medical procedure was begun,
patients were investigated for the presence of anorexia,
weight loss, smoking and drinking water status. The con-
trols were recruited from hospital attendees in two centers
with no family history of gastric cancer. They were
matched with patients for age and sex, without any malig-
nant diseases and infectious disorders.
Information on smoking and drinking water status was
obtained by interview. We did not obtain dietary histo-
ries, such as details of meat or fish consumption. We
defined "current" as persons who were current smokers,
"ex-" as those who had smoked in the past, and "never" as
those who had never smoked at any time in their life.
Weight loss during the proceeding 6 months was
expressed as a percentage of the usual weight and patients
were divided into 2 groups according to the severity of
weight loss: Non-cachexia group, weight loss ≤ 10 %;
Cachexia group, > 10%.
Assessment of H pylori status
14C-UBT test was repeated two times for enrolled patients
and controls by a single team of specialized staff. None ofBMC Cancer 2007, 7:45 http://www.biomedcentral.com/1471-2407/7/45
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the enrolled subjects had ever been treated for H pylori
eradication.
DNA extraction
The genomic DNA was purified from 5 ml of peripheral
blood samples using Wizard Genomic DNA Purification
kit (Promega) according to the manufacture's instruction.
IL-1B+3954 C/T
This polymorphism was investigated using restriction
fragment length polymorphism analysis of polymerase
chain reaction products as previously studied [16].
IL-1B-31 T/C
Forward, TCTTTTCCCCTTTCCTTTAACT; reverse, GAGA-
GACTCCCTTAGCACCTAGT [17] (Nanjing Bio Eng Co.).
PCR conditions: 10 min at 95°C; 40 cycles of 30 sec at
72°C, 15 sec at 95°C, 20 sec at 52°C (BIO-RAD, Japan).
PCR products were digested by restriction endonuclease
Alul (Promega) and visualized by electrophoresis on a
2.5% agarose gel stained with 0.1% ethidium bromide.
Alleles were coded as follows: C allele: 234 bp; T allele:
150 bp and 84 bp.
IL-1B-511C/T
Forward, 5-TGGCATTGATCTGGTTCATC-3, reverse, 5-
GTTTAGGAATCTTCCCACTT-3 [18] (Nanjing Bio Eng
Co.). PCR conditions: 95°C 1 minute; 30 cycles of 95°C
30 sec, 55°C 30 sec, 72°C 30 sec; 70°C 7 min (BIO-RAD,
Japan). PCR products were digested by restriction endo-
nuclease Aval (Promega) and visualized by electrophore-
sis on a 2.5% agarose gel stained with 0.1% ethidium
bromide. Alleles were coded as follows: T: 304 bp, C: 190
and 114 bp.
IL-1RN VNTR
Forward, 5-CTCAGCAACACTCCTAT-3, reverse, 5-TCCT-
GGTCTGCAGGTAA-3 [19] (Nanjing Bio Eng Co.). PCR
conditions: 94°C for 4 min, 32 cycles of 94°C for 1 min,
50°C for 1 min, 72°C for 1 min ; 72°C for 10 min (BIO-
RAD, Japan). PCR products were analyzed by electro-
phoresis on a 2% agarose gel stained with ethidium bro-
mide. Alleles 1–5 (IL1RN*1-IL1RN*5) were detected
according to their sizes relative to a 100 bp DNA ladder:
allele 1 (four repeats) 410 bp; allele 2 (two repeats) 240
bp; allele 3 (five repeats) 500 bp; allele 4 (three repeats)
325 bp. Allele 5 (six repeats; 595 bp) was not observed in
the study population.
Statistical analysis
Descriptive data of continuous variables were reported as
mean ± SD and tested by Student's t-test by SPSS 11.0. The
differences in allele frequency among groups were exam-
ined for statistical significance with chi-square test or
Fisher exact test when appropriate. Analysis was com-




Within each study group, the genotype distributions were
consistent with those predicted by the Hardy-Weinberg
equilibrium (table 1 and table 2.).
Characteristics of the study population
On the basis of the selection criteria, 214 patients with
locally advanced gastric cancer were studied. Of these, 91
patients had a greater than 10% weight loss within a six-
month period (cachexia group). The characteristics of the
study population were shown in table 3. No significant
difference was noted in sex, age, tumor stage and locations
between patients with cachexia and those without.
The clinical characteristics of the controls and the patients
were shown in table 4.
Gene polymorphisms in patients with locally advanced 
gastric cancer and controls
No significant difference was found in allele frequency
between patients and controls (Table 5).
Distribution of alleles studied in patients with locally 
advanced gastric cancer
Details of the comparison of alleles in patients with gastric
cancer are shown in table 6. No significant differences
were found in the distributions of IL-1-31 T, -511 T and
Table 1: Hardy-Weinberg equilibrium analysis in patients with 
cancer and controls.
Cancer (n = 214) Contr. (n = 230)
Observed Expected Observed Expected
IL-1β- 3 1C C 4 84 5 . 35 34 9 . 8
CT 101 95.1 108 114.4
TT 75 73.6 69 65.8
P 0.980 0.835
IL-1β-511 CC 55 50.1 56 49.3
CT 97 106.8 101 114.4
TT 62 57.1 73 66.3
P 0.638 0.454
IL-1β+3594 CC 178 179.5 201 201.9
CT 36 33 29 27.2
T T 01 . 500 . 9
P 0.442 0.619
IL-1RN VNTR 1/1 157 156.5 168 167
1/2 45 54 50 58.8
2/2 5 3.5 6 4.2
1/3 5 0 4 0
1/4 2 0 2 0
P 0.089 0.135
Genotypes did not deviate from the Hardy – Weinberg equilibrium.BMC Cancer 2007, 7:45 http://www.biomedcentral.com/1471-2407/7/45
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IL-1RN VNTR allele between cachexia group and non-
cachexia group.
As to IL-1B+3594 polymorphism, IL-1B+3594 T allele was
seen significantly more frequently in the patients with
cachexia than without (χ2 = 5.556, P = 0.018).
Logistic regression
Logistic regression adjusted for actual weight, carcinoma
location and stage, the IL-1β+3954 CT genotype was asso-
ciated with an odds ratio of 2.512 (95% CI, 1.180 –
5.347) for cachexia (table 7).
Discussion
In view of the inflammatory nature of cancer cachexia, we
explored the role of polymorphisms in genes related to
inflammation in gastric cancer. The frequency of IL-1B-31
T, -511 T, +3954 T and IL-1RN VNTR alleles found in this
study is comparable to the previous reports in China [20-
22]. We found that polymorphisms studied are not asso-
ciated with a significantly increased risk of locally
advanced gastric cancer. However, a significantly
increased frequency of IL-1B+3954 T allele was noted in
patients with cachexia from locally advanced gastric can-
cer, which has not been reported previously.
Before evaluating the role of a cytokine polymorphism
played in a disease, three questions need to be answered
[23,24]. First, are the subjects homogeneous? To avoid
artifact in population admixture, we selected only Chi-
nese Han people in China. In addition, the consanguine-
ous mating subjects were precluded from our study.
Second, does the product of the studied gene play an
important role in the pathogenesis of the disease? The
central roles for IL-1β in the occurrence of cachexia have
been demonstrated by many studies [3,5,25]. Third, does
Table 3: Characteristics of the patients with locally advanced gastric cancer.
Cachexia (n = 91) Non-cachexia (n = 123) P
Sex (M/F) 55/36 72/51 0.7793
Age (year) 55.5 ± 15.0 57.0 ± 13.5 0.4443
Serum albumin (g/L) 30.5 ± 4.7 36.3 ± 6.1 <0.001
Actual weight (kg) 55.1 ± 9.0 57.2 ± 6.3 0.0584
Anorexia (n) 39 46 0.4198
Carcinoma location Middle third 56 90 0.071
Low third 35 33
Carcinoma stage III 65 101 0.064
IV 26 22
No significant difference was noted in sex and age.
Table 2: Hardy-Weinberg equilibrium analysis in Non-cachexia group and Cachexia group.
Non-cachexia (n = 123) Cachexia (n = 91)
Observed Expected Observed Expected
IL-1β- 3 1 C C2 62 4 . 11 21 2 . 7
CT 57 60.7 44 42.6
TT 40 38.1 35 35.7
P 0. 889 0.976
IL-1β-511 CC 31 27.8 24 22.3
CT 55 61.4 42 45.4
TT 37 33.8 25 23.3
P 0.716 0.881
IL-1β+3594 CC 109 109.4 69 70.3
CT 14 13.2 22 19.4
T T00 . 401 . 3
P 0.809 0.480
IL-1RN VNTR 1/1 91 90.5 66 66.0
1/2 25 30.5 20 23.4
2/2 3 2.0 2 1.6
1/3 3 0.0 2 0.0
1/4 1 0.0 1 0.0
P 0.316 0.510
Genotypes did not deviate from the Hardy – Weinberg equilibrium.BMC Cancer 2007, 7:45 http://www.biomedcentral.com/1471-2407/7/45
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the gene polymorphism produce a relevant alteration in
the level or function of the gene product? In vitro and in
vivo studies have indicated that these alleles enhance IL-
1β and IL-1RN productions and the circulating levels of
the two cytokines in humans [10,11].
Since El-Omar et al [26] reported that IL-1B-31CC and IL-
1RN*2/*2 genotypes were associated with a significantly
increased risk of GC in Caucasians, some contradictory
results from studies in different countries have been
reported. Therefore, before evaluating the role of a
cytokine polymorphism played in cachexia associated
with gastric cancer, one important question need to be
answered. Are the gene polymorphisms studied correlated
with gastric cancer? In the present study, we investigated
the roles of IL-1B-31 T/C, -511 C/T, +3954 C/T and IL-
1RN VNTR as host risk factors for gastric cancer, but failed
to demonstrate an association between polymorphisms
studied and gastric cancer susceptibility. Susceptibility to
gastric cancer in patients with proinflammatory genetic
profile is a fascinating hypothesis that has been mainly
confirmed in studies from Poland [26], Portugal [27,28],
and the America [29]. In contrast, other studies performed
in Asian failed to confirm this finding [20,30,31].
Although there is no clear explanation for these conflict-
ing results, the different genetic background of Western
and Asian populations could be an important factor. In
addition, gastric cancer is a multifactorial disease. The
marked geographic variation, time trends, and the migra-
tory effect on gastric cancer incidence suggest that envi-
ronmental or lifestyle factors are major contributors to the
etiology of this disease. Thus, it is necessary to perform
large-scale case-control studies considering lifestyle fac-
tors such as diet and drinking habits before a final state-
ment of the role of IL-1B gene polymorphism in gastric
cancer can be made. However, our present study from this
Chinese population provides evidence that no association
was seen between polymorphisms studied and gastric can-
Table 5: Comparison of alleles between patients with cancer and controls.
Cancer (n = 214) Contr. (n = 230) P
IL-1β-31 CC 48 53
CT 101 108
TT 75 69
T allele 251(58.6 %) 246(53.5%) 0.121
IL-1β-511 CC 55 56
CT 97 101
TT 62 73
T allele 221(51.6%) 237 (53.7%) 0.973
IL-1β+3594 CC 178 201
CT 36 29
TT 0 0
T allele 36 (8.4 %) 28 (6.3%) 0.228




1/4 2 2 0.992
No significant difference was found in allele frequency between patients with cancer and controls
Table 4: Characteristics of the patients and controls.
Cancer (n = 214) Contr. (n = 230) P
Sex (M/F) 127/87 140/90 0.743
Age (year) 56.4 ± 14.3 55.0 ± 13.5 0.280
Smoking status never 85 (39.7%) 95 (41.3%) 0.714
Ex- 32 (15.0%) 39 (17.0%)
current 97 (45.3%) 96 (41.7%)
Helicobacter pylori infection 125 (58.4%) *124 (59.9%) 0.756
Poor drinking water (well water) 31 (14.5%) 22 (9.6%) 0.110
* Twenty-three controls missed. No significant association was found between the frequency of smoking status, poor drinking water status and 
Helicobacter pylori infection. The two groups were matched for age and sex.BMC Cancer 2007, 7:45 http://www.biomedcentral.com/1471-2407/7/45
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cer, and thus no evidence that these loci contribute to
advanced gastric cancer susceptibility.
While the precise mechanism of cachexia is unclear it is
self evident that the inflammatory process is exceedingly
strong in weight losing cancer patients [32]. In this study,
we examined the cytokine polymorphism frequencies in
the patients with locally advanced gastric. However, the
distribution of cytokine polymorphisms within the
patients varied, with IL-1B+3954 T allele being found sig-
nificantly more frequently in the cachexia patients than in
non-cachexia patients (P  < 0.05). Logistic regression
adjusted for actual weight, carcinoma location and stage,
the IL-1β+3954 CT genotype was associated with an odds
ratio of 2.512 (95% CI, 1.180 – 5.347) for cachexia. In
vitro study demonstrated that IL-1β+3594 T at the 5th
exon significantly influences the production of IL-1β [10].
Therefore, we induce that gene-controlled high produc-
tion of IL-1β are likely to play some role in the occurrence
of cachexia from patients with advanced gastric cancer.
However, in studies with a relatively small sample size,
such as the present study, attention should be paid to the
evaluation of significant factors suggested by statistical
analysis, especially when they have relatively large P val-
ues (0.01 <P < 0.05). There is a possibility that such fac-
tors show a false-positive result.
There are several strengths of our gene association study.
First, patients were recruited from two centers; the
number of patients is relatively big compared with studies
with smaller sample size. Second, to avoid artifact in pop-
ulation admixture, we selected only Chinese Han people
in China, thus limiting the chance of population stratifi-
cation due to ethnic. Third, we studied four separate but
related genes, which allows direct comparison of the
results of each gene polymorphism association with out-
come. However, the interpretation of our study results is
limited because it might be more valuable to measure the
actual level or to assess the expressions of IL-1β in the gas-
tric mucosa according to the polymorphisms. In addition,
we didn't evaluate the protein loss of the subjects because
such factor was difficult to be expressed numerically and
to be evaluated objectively. Doubtless, further studies will
identify whether the product of the studied genes play an
important role in the pathogenesis of cachexia from
advanced gastric cancer.
Conclusion
In summary, the present study from this Chinese popula-
tion provides evidence that IL-1β allele may contribute to
the occurrence of cachexia associated with locally
advanced gastric cancer. Studies with large sample sizes
and multiple SNPs of other important cytokines are
needed to further elucidate the genetic factors involved in
the etiology of cachexia from gastric cancer.
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Table 7: Logistic Regression Analysis in patients with gastric 
caner.
β 95% C.I S.E P
IL-1β +3954 0.921 2.512(1.180, 5.347) 0.386 0.017
Binary Logistic regression. Method = Stepwise (Conditional). Logistic 
regression adjusted for actual weight, carcinoma location and stage, 
the IL-1β +3954 CT genotype was associated with an odds ratio of 
2.512 (95% CI, 1.180 – 5.347) for cachexia
Table 6: Distribution of alleles in the patients with cancer.
Non-cachexia 
(n = 123)
Cachexia (n = 91) P
IL-1β-31 CC 26 12
CT 57 44
TT 40 35
T allele 137 (55.7 %) 114(62.6 %) 0.194
IL-1β-511 CC 31 24
CT 55 42
TT 37 25
T allele 109 (44.3 %) 92 (50.5%) 0.376
IL-1β+3594 CC 109 69
CT 14 22
TT 0 0
T allele 14 (5.7 %) 22 (12.1 %) 0.018




1/4 1 1 0.997
*χ2 = 5.556,P = 0.018. Significant difference was found in T allele 
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